Secretome proteomics for discovery of cancer biomarkers
โ Scribed by Manousos Makridakis; Antonia Vlahou
- Publisher
- Elsevier
- Year
- 2010
- Tongue
- English
- Weight
- 397 KB
- Volume
- 73
- Category
- Article
- ISSN
- 1874-3919
No coin nor oath required. For personal study only.
โฆ Synopsis
"Secretome" is referred to as the rich, complex set of molecules secreted from living cells. In a less strict definition frequently followed in "secretome" studies, the term also includes molecules shed from the surface of living cells. Proteins of secretome (will be referred to as secreted) play a key role in cell signaling, communication and migration. The need for developing more effective cancer biomarkers and therapeutic modalities has led to the study of cancer cell secretome as a means to identify and characterize diagnostic and prognostic markers and potential drug and therapeutic targets. Significant technological advances in the field of proteomics during the last two decades have greatly facilitated research towards this direction. Nevertheless, secretome analysis still faces some difficulties mainly related to sample collection and preparation. The goal of this article is to provide an overview of the main findings from the analysis of cancer cell secretome. Specifically, we focus on the presentation of main methodological approaches that have been developed for the study of secreted proteins and the results thereof from the analysis of secretome in different types of malignancies; special emphasis is given on correlation of findings with protein expression in body fluids.
๐ SIMILAR VOLUMES
## Abstract Chromatography and electrophoresis have been used for the last halfโcentury to separate small and large molecules. Advances in MS instrumentation and techniques for sample introduction into the mass analyzer (i.e. matrixโassisted laser desorption/ionization and electrospray ionization),
## Abstract ## BACKGROUND The advent of the prostateโspecific antigen (PSA) test has had a profound impact on the diagnosis and treatment of prostate carcinoma. However, the use of PSA levels alone for screening for prostate carcinoma was compromised by the variations in the amount of PSA produced
## Abstract Lung cancer is a devastating illness with an overall poor prognosis. To effectively address this disease, early detection and novel therapeutics are required. Early detection of lung cancer is challenging, in part because of the lack of adequate tumor biomarkers. The goal of this review